Buy Immunomedics Stock | IMMU Stock Price & Latest News | Public.com
IMMU

Immunomedics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Immunomedics (IMMU) stock trends here

    About IMMU

    Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was found...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.11
    -0.23
    -0.34
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.34

    Actual EPS
    Q1 2021

    Stats

    Market Cap$20,3B
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$87.93
    1 Year Low$8.80
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app